Financial Ratios

MEDICORP TECHNOLOGIES INDIA LTD.

NSE : NABSE : 532108ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE72.900 (0 %)
PREV CLOSE ( ) 72.90
OPEN PRICE ( ) 72.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )71.50 73.90
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2002Mar2001Mar2000Mar1999Mar1998
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.51-1.641.670.51-1.40
   CEPS(Rs)-1.33-0.762.641.63-0.92
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)3.438.3512.056.387.22
   Tax Rate(%)24.300.0011.430.000.00
Margin Ratios
   Core EBITDA Margin(%)2.026.2022.0422.15-6.64
   EBIT Margin(%)-1.013.0919.3917.61-15.61
   Pre Tax Margin(%)-15.70-9.8410.142.98-31.05
   PAT Margin (%)-11.89-9.848.982.98-31.05
   Cash Profit Margin (%)-6.32-4.5412.699.46-20.41
Performance Ratios
   ROA(%)-4.57-3.675.451.17-4.29
   ROE(%)-42.64-16.1023.497.50-17.42
   ROCE(%)-0.501.4714.758.17-2.37
   Asset Turnover(x)0.380.370.610.390.14
   Sales/Fixed Asset(x)0.780.901.270.710.34
   Working Capital/Sales(x)1.671.752.241.831.02
Efficiency Ratios
   Fixed Capital/Sales(x)1.271.110.791.412.95
   Receivable days124.78137.39109.08118.65113.30
   Inventory Days112.83125.2664.5377.66173.84
   Payable days150.80212.64163.14190.79195.02
Valuation Parameters
   PER(x)0.000.0012.8340.730.00
   PCE(x)-6.11-22.028.1212.820.00
   Price/Book(x)2.382.001.783.280.00
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)2.512.961.893.268.81
   EV/Core EBITDA(x)52.1533.608.0212.87-161.50
   EV/EBIT(x)-235.0891.159.5517.60-51.34
   EV/CE(x)0.850.921.001.080.95
   M Cap / Sales0.411.051.051.280.00
Growth Ratio
   Net Sales Growth(%)25.93-21.94104.30293.54314.75
   Core EBITDA Growth(%)-31.17-70.8990.271928.14-221.97
   EBIT Growth(%)-141.43-87.22118.50524.82-1792.77
   PAT Growth(%)-52.95-187.85498.81136.09-1571.15
   EPS Growth(%)-52.95-198.22225.08136.66-1544.39
Financial Stability Ratios
   Total Debt/Equity(x)6.692.651.075.113.68
   Current Ratio(x)2.822.372.502.432.49
   Quick Ratio(x)1.911.401.731.771.48
   Interest Cover(x)-0.070.242.101.20-1.01
   Total Debt/Mcap(x)4.941.740.731.60

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.